Non-hallucinogenic psychedelics

Attitudes towards psychedelics are evolving, with growing evidence supporting their potential to treat a range of mental health conditions including anxiety, depression, post-traumatic stress disorder and addiction. In 2023, Australia became the first country in the world to approve psychedelics to treat specific mental health conditions. A handful of other countries are also moving in that direction.